Loading company…
Riskpilot
← Back to search
Sign in
Get full access
DOKTOR INNOVASJON AS
AS
Active
Org 929512693
Wilhelm Færdens Vei 3B, 0361 Oslo
Other education n.e.c. · NACE 8559
Est. 2022
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 102K
+33% vs 2023
EBITDA margin
14.8%
-25% vs 2023
Equity ratio
78.5%
Financial strength
Net profit 2024
NOK 457
-97% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 102K
+33%
EBITDA
NOK 15K
-25%
Net profit
NOK 457
-97%
Total assets
NOK 353K
-9%
Equity
NOK 277K
+0%
Employees
0
—
Company information
Legal name
DOKTOR INNOVASJON AS
Org number
929512693
Legal form
Aksjeselskap
NACE code
8559 · Other education n.e.c.
Founded
20. juli 2022
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Konsulenttjenester innen helse, legetjenester, foredragsholder og undervisning, samt investering i andre selskaper.
Contact
Address
Wilhelm Færdens Vei 3B, 0361 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other education n.e.c.
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2022
2023
2024
Revenue
128
76
102
Staff expenses
−0
−0
−0
EBITDA
79
20
15
Depreciation & amort.
−0
−0
−0
EBIT
79
20
15
Net financials
168
2
−10
Profit before tax
247
22
5
Tax
17
5
4
Net profit
229
17
0
Balance sheet
NOK thousands
Item
2022
2023
2024
Total assets
352
388
353
Equity
274
276
277
Long-term debt
0
0
0
Short-term debt
78
112
76
Total debt
78
112
76
Financial ratios
5-year trend
EBITDA margin
14.8%
This company
15.8%
Market median
-6% vs market
2022
2024
Equity ratio
78.5%
This company
38.2%
Market median
+105% vs market
2022
2024
Return on equity
0.2%
This company
18.4%
Market median
-99% vs market
2022
2024
Net profit margin
0.5%
This company
8.1%
Market median
-94% vs market
2022
2024
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
2022
2024
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-06-01 – 2022-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
IS
Ida Susanna Fattah
Chairman
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
DOKTOR INNOVASJON AS
(this company)
MEDLYTIC AS
Board network connections
Board members of DOKTOR INNOVASJON AS also hold positions in
0
other companies.
Person
Role here
Other companies
Ida Susanna Fattah
Chairman
0 companies